| Volume 10, 2006 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: A Decade of IJPC
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 2
|
CompoundingToday.com: Literature, Book Reviews, & More
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 5
|
Compounding Pharmacy: The Past Decade
Kuntz Rachael
|
Jan/Feb 2006
Pg. 6-7
|
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh
Vail Jane
|
Jan/Feb 2006
Pg. 9-11
|
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Heim Bob
|
Jan/Feb 2006
Pg. 14-18
View Sample |
Pharmaceutical Legislation: An Historical Perspective
Worthen Dennis B
|
Jan/Feb 2006
Pg. 20-28
|
Pharmacy Compounding Urban Legends
Kastango Eric S
|
Jan/Feb 2006
Pg. 32-34
|
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations
Dawson Michael F
|
Jan/Feb 2006
Pg. 36-39
|
Quality Control Analytical Methods: Common Concerns about Out-of-Specification Results
Lanier Lance, Kemp Jesse
|
Jan/Feb 2006
Pg. 41-42
|
Acacia and Mineral Oil Emulsion NF
Al-Achi Antoine, Mosley Anita, Patlolla Swapna
|
Jan/Feb 2006
Pg. 44
|
How'd They Do That?
Roberts Jerrod L
|
Jan/Feb 2006
Pg. 46-49
|
Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success
Vail Jane
|
Jan/Feb 2006
Pg. 50-55
|
Standard Operating Procedure: Shipping of Prescriptions
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 56-57
|
Calculations
Prince Shelly J
|
Jan/Feb 2006
Pg. 58
|
Chlorambucil 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 59
|
Dantrolene Sodium 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 60
|
Domperidone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 61
|
Efavirenz 20-mg/mL Oral Liquid, Anhydrous
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 62
|
Medium-Chain Triglycerides Oral Vehicle, Anhydrous
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 63
|
Mercaptopurine 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 64
|
Misoprostol 1-mg Suppository
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 65
|
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 66
|
Propylthiouracil 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 67
|
Thioguanine 40-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 68
|
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management
Nguyen-Xuan Tho, Griffiths William, Kern Christian, Van Gessel Elisabeth, Bonnabry Pascal
|
Jan/Feb 2006
Pg. 69-73
|
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds
Rhodes Richard S, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok
|
Jan/Feb 2006
Pg. 74-78
|
Scientific and Professional Reviewers for 2005
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 79
|
PostScription: Stopping Drug Reps at the Door
Brewer Benjamin
|
Jan/Feb 2006
Pg. 80
|
Calculations
Prince Shelly J
|
Mar/Apr 2006
Pg. 136
|
Amlodipine 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 137
|
Chloroquine Phosphate 15-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 138
|
Cimetidine 60-mg/mL Oral Liquid, Alcohol Free
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 139
|
Disopyramide Phosphate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 140
|
Mycophenolate Mofetil 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 141
|
Norfloxacin 20-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 142
|
Saquinavir 60-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 143
|
Sotalol Hydrochloride 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 144
|
Terbinafine Hydrochloride 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 145
|
Trazodone Hydrochloride 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 146
|
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis
Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
|
Mar/Apr 2006
Pg. 147-153
|
Chemical Stability of Diclofenac Sodium Injection
Gupta Vishnu D
|
Mar/Apr 2006
Pg. 154-155
|
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol
McNulty Jack P
|
Mar/Apr 2006
Pg. 159-160
|
PreScription: The Squeaky Wheel Gets the Grease!
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 82
|
Erratum: Allen LV Jr. Lidocaine hydrochloride 2%, misoprostol 0.0024%, and phenytoin 2% topical wound powder. IJPC 2004; 8(4): 298
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 82
|
Compounding Pharmacy: The Past Decade, Part 2 -- Equipment Advances
Kuntz Rachael
|
Mar/Apr 2006
Pg. 86-87
|
Hospice from a Compounding Pharmacist's Perspective
Jones Marty
|
Mar/Apr 2006
Pg. 89-93
|
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
|
Mar/Apr 2006
Pg. 95-98
|
The Story of Hospice
Kuntz Rachael
|
Mar/Apr 2006
Pg. 100-102
|
The Dying Process
Fonseca Simonne C
|
Mar/Apr 2006
Pg. 103-106
|
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Vail Jane
|
Mar/Apr 2006
Pg. 107-111
|
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist
Jeffrey Megan
|
Mar/Apr 2006
Pg. 113-119
|
Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations
Fonseca Simonne C
|
Mar/Apr 2006
Pg. 122-127
|
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1
Wagner James T
|
Mar/Apr 2006
Pg. 128-133
|
Standard Operating Procedure: Labconco Basic 47 Laboratory Hood
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 135
|
Extended Stability of Oxytocin in Common Infusion Solutions
Trissel Lawrence A, Zhang Yanping, Douglass Kate, Kastango Eric
|
Mar/Apr 2006
Pg. 156-158
|
PreScription: Standards, Legal Standards, and Accreditation
|
May/Jun 2006
Pg. 162
|
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana, Kirshbaum Karen
|
May/Jun 2006
Pg. 165-171
|
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Fields Shannon W
|
May/Jun 2006
Pg. 172
|
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna, Jones William, Stephenson Douglas M M
|
May/Jun 2006
Pg. 175-183
|
Probiotic Therapy, Part 2: Clinical Perspectives
Vail Jane
|
May/Jun 2006
Pg. 195-200
|
Quick Tips for Managing Market Directors
Baker Lisa M
|
May/Jun 2006
Pg. 201
|
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006
Pg. 202-204
|
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions
Allen Loyd V Jr
|
May/Jun 2006
Pg. 218
|
Calculations
Prince Shelly J
|
May/Jun 2006
Pg. 219
|
Carvedilol 1.25-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 220
|
Enalapril Maleate 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 221
|
Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update
Hu Fei-Shu, Reed-Kane Dana, Draugalis JoLaine R
|
May/Jun 2006
Pg. 187-192
|
Basics of Compounding for Dentistry, Part 2: Tooth Whitening
Fonseca Simonne C
|
May/Jun 2006
Pg. 205-207
|
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2
Wagner James T
|
May/Jun 2006
Pg. 208-211
|
Wise Buys: Choosing the Right Software for a Compounding Pharmacy
Vail Jane
|
May/Jun 2006
Pg. 213-216
|
Granisetron 0.05-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 222
|
Lamotrigine 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 223
|
Mesna 20-mg/mL Syrup
Allen Loyd V Jr
|
May/Jun 2006
Pg. 224
|
Mexiletine Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 225
|
Pyrimethamine 2-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 226
|
Quinapril 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2006
Pg. 227
|
Theophylline 5-mg/mL Oral Liquid, Alcohol-Free
Allen Loyd V Jr
|
May/Jun 2006
Pg. 228
|
Triamcinolone Acetonide 0.1% Mouthwash Solution
Allen Loyd V Jr
|
May/Jun 2006
Pg. 229
|
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration
Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006
Pg. 230-233
|
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration
Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
|
May/Jun 2006
Pg. 234-236
|
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together
Gupta Vishnu D
|
May/Jun 2006
Pg. 237-239
|
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk!
Mason Dave
|
May/Jun 2006
Pg. 240
|
Compounded Treatment Options for Cystitis and Other Bladder Problems
McElhiney Linda F
|
Jul/Aug 2006
Pg. 270-275
|
Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces
Acosta W Renee, Salzman Robert D
|
Jul/Aug 2006
Pg. 277-280
|
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Zolner William J
|
Jul/Aug 2006
Pg. 281-284
|
What are You Willing to Do?
Moore Renee
|
Jul/Aug 2006
Pg. 287
|
Hospice Symptom Relief Kit: An Update
Petrin Ronald L
|
Jul/Aug 2006
Pg. 288-290
|
Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight
Vail Jane
|
Jul/Aug 2006
Pg. 291-292
|
Aseptic Compounding in New Zealand and the Use of Still Air Boxes
Gargiulo Derryn, Kairuz Therese Eileen
|
Jul/Aug 2006
Pg. 293-295
|
Standard Operating Procedure: Testing of Water Supply: Barnstead D4751 High Purity Water System
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 296-297
|
Calculations
Epshteyn Mikhail
|
Jul/Aug 2006
Pg. 298
|
Adderall 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 299
|
Dapsone 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 300
|
Itraconazole 40-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 301
|
Lisinopril 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 302
|
Nifedipine 4-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 303
|
Propranolol Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 304
|
Rifabutin 20-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 305
|
Sildenafil Citrate 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 306
|
Tramadol Hydrochloride 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 307
|
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 308
|
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free
Gupta Vishnu D
|
Jul/Aug 2006
Pg. 318-319
|
PostScription: Patients or Clients?
Frieders Larry J
|
Jul/Aug 2006
Pg. 320
|
PreScription: 6-Year or 7-Year Program?
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 242
|
Introduction to Hospital Compounding
McElhiney Linda F
|
Jul/Aug 2006
Pg. 245-250
|
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729>
Driscoll David F, Nehne Jorg, Horst Peterss, Klutsch Karsten, Bistrian Bruce R, Wilhelm Niemann
|
Jul/Aug 2006
Pg. 309-315
|
Stability of Memantine in an Extemporaneously Prepared Oral Liquid
Yamreudeewong Weeranuj, Teixeira M Glaucia, Mayer Gabriele E
|
Jul/Aug 2006
Pg. 316-317
|
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations
Douglass Kate
|
Jul/Aug 2006
Pg. 253-261
|
Putting the Science Back into the "Art and Science" of Compounding
Kastango Eric S
|
Jul/Aug 2006
Pg. 263-268
|
PreScription: Certification and Accreditation
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 322
|
Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
|
Sep/Oct 2006
Pg. 324-328
|
Mesotherapy: Cosmetic Applications
Stachowski Jill, Botts Kayla, Rine Lesley, Kato Danielle, Pollock Jennifer
|
Sep/Oct 2006
Pg. 331-334
|
Dermatological Effects from Years in the Sun: Compounding Opportunities
Jones Marty
|
Sep/Oct 2006
Pg. 336-342
|
Migraine: A General Approach to Prevention and Treatment
Kennedy Bonnie M
|
Sep/Oct 2006
Pg. 344-350
|
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches
Williams Steve D
|
Sep/Oct 2006
Pg. 351
|
University of North Carolina at Chapel Hill School of Pharmacy Pharmaceutical Care Laboratories: Compounding Laboratory Curriculum and Renovation
Shrewsbury Robert P
|
Sep/Oct 2006
Pg. 353-358
|
Education, Training, and Evaluation of Hospital Compounding Personnel
McElhiney Linda F
|
Sep/Oct 2006
Pg. 361-368
|
MEDLINE: A Valuable Research Tool for the Compounding Pharmacist
Kuntz Rachael
|
Sep/Oct 2006
Pg. 369-371
|
Quality-Control Analytical Methods: Sterility Failure Investigations
Venti Eden M
|
Sep/Oct 2006
Pg. 372-375
|
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 377-379
|
Calculations
Prince Shelly J
|
Sep/Oct 2006
Pg. 380
|
Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 381
|
Famotidine 8-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 382
|
Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 383
|
Hydroxyurea 100 mg/mL
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 384
|
Indinavir 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 385
|
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 386
|
Midazolam Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 387
|
Nitrazepam 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 388
|
Omeprazole 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 389
|
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 390
|
Pantoprazole Sodium 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 391
|
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Bigeleisen Paul E
|
Sep/Oct 2006
Pg. 392-395
|
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel Lawrence A, Zhang Yanping, Koontz Susannah E
|
Sep/Oct 2006
Pg. 396-399
|
PostScription: Moving Pharmacy Compounding into the 21st Century and Beyond
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 400
|
PreScription: International Journal of Pharmaceutical Compounding is Expanding
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 402
|
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
|
Nov/Dec 2006
Pg. 428-433
|
Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
|
Nov/Dec 2006
Pg. 434-435
|
Equipment, Supplies, and Facilities Required for Hospital Compounding
McElhiney Linda F
|
Nov/Dec 2006
Pg. 436-441
|
Chloral Hydrate 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 453
|
Cyclophosphamide 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 454
|
Disulfiram 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 455
|
Gabapentin 100-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 456
|
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 457
|
Indomethacin 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 458
|
Naltrexone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 459
|
Terbutaline Sulfate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 460
|
Valacyclovir 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 461
|
PostScription: Challenges Facing an Analytical Laboratory
Kupiec Thomas C
|
Nov/Dec 2006
Pg. 479-480
|
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Nov/Dec 2006
Pg. 462-468
|
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations
Piette Marie, Stassen Thibaut, Kinget Renaat, Delattre Luc
|
Nov/Dec 2006
Pg. 469-477
|
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Davidson Gigi S
|
Nov/Dec 2006
Pg. 405-408
|
Compounding for Feline Herpetic Keratitis
Davidson Gigi S
|
Nov/Dec 2006
Pg. 411-414
|
Compounding for Veterinary Medicine
Fields Shannon W
|
Nov/Dec 2006
Pg. 417-418
|
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
|
Nov/Dec 2006
Pg. 418
|
Taurine for the Treatment of Canine Dilated Cardiomyopathy
Vail Jane
|
Nov/Dec 2006
Pg. 421-424
|
Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard)
Benischek Rita L, Riffell Gregory S, Mauldin Todd
|
Nov/Dec 2006
Pg. 426-427
|
Quality Control Analytical Methods: Continuous Quality Improvement
Venti Eden M
|
Nov/Dec 2006
Pg. 442-444
|
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 446-448
|
Calculations: Compounding for Large and Small Animals
Stockton Shelly J
|
Nov/Dec 2006
Pg. 449
|
Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 450-451
|
Amiloride Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 452
|
